INBRAIN NEUROELECTRONICS SL

Their core work

INBRAIN NEUROELECTRONICS is a Barcelona-based deep-tech SME developing graphene-based neural interface technologies. Their company name points directly to their application domain: electronic devices designed to interact with the nervous system, most likely for neural recording, stimulation, or brain-computer interface purposes. Within the EU Graphene Flagship — Europe's largest coordinated research initiative — they contribute expertise at the intersection of 2D materials science and bioelectronics, where graphene's unique electrical and biocompatibility properties make it a promising material for implantable neural devices. Their participation in the 2D Experimental Pilot Line (2D-EPL) signals that they are also building capability in scaling graphene-based components from lab prototypes toward manufacturable products.

What they specialise in

How they've shifted over time

Both H2020 projects began in 2020, so the timeline is short and direct before-vs-after comparisons are limited. That said, a discernible shift is visible in the keyword data: early Flagship participation centers on graphene at the core research level, while more recent activity introduces broader "2D materials" and, critically, "pilot line" — indicating a move beyond graphene alone toward a wider class of 2D materials and toward manufacturing-scale processes. For a deep-tech SME in neuroelectronics, this trajectory — from fundamental Flagship research toward pilot-line involvement — suggests growing technology maturity and early steps toward commercial readiness.

INBRAIN is moving from pure materials research toward applied manufacturing infrastructure for 2D materials, suggesting they are positioning their graphene-based neural device technologies for eventual commercial production.

How they like to work

INBRAIN participates exclusively as a consortium member — never as coordinator — which is typical for a young, specialized SME that joins large flagship initiatives to access shared infrastructure, fabrication tools, and knowledge networks. Their 198 unique partners across just 2 projects is explained by the Graphene Flagship's massive umbrella structure, where hundreds of organizations collaborate under a single programme. This means they are embedded in one of Europe's best-connected advanced materials networks, but their direct bilateral working relationships within it are hard to assess from public data alone.

INBRAIN has collaborated with 198 unique partners across 21 countries — an unusually large network for a 2-project SME, explained entirely by their Graphene Flagship membership, which spans most of Europe's leading materials science institutions. Their geographic footprint likely reflects the Flagship's own node structure rather than independently built bilateral ties.

What sets them apart

INBRAIN occupies a rare intersection in the European deep-tech landscape: a commercial SME applying graphene and 2D materials specifically to neural interfaces — a high-value, clinically-oriented target that most Graphene Flagship participants (universities, large electronics firms) do not pursue. This gives them a distinctive profile as the application-side voice in a research-heavy consortium, bridging frontier materials science with a defined medical technology end-use. For any consortium needing a connection between graphene research and brain-computer interface or implantable bioelectronics, INBRAIN is among very few European SMEs with exactly this profile.

Highlights from their portfolio

• GrapheneCore3
  Core project of the Graphene Flagship — Europe's largest single research initiative — placing INBRAIN inside the continent's most influential advanced materials network and giving them access to its full industrial and academic consortium.
• 2D-EPL
  A longer-running project (2020–2024) focused on an experimental pilot line for 2D materials, directly addressing manufacturing scale-up and putting INBRAIN at a critical juncture between research and production readiness.